跳至主要内容
临床试验/JPRN-UMIN000026440
JPRN-UMIN000026440尚未招募4 期

Clinical trial to evaluate the effect of Leucomycin A3 (Josamycin) in severe and very severe community-acquired pneumonia in Filipino children 2-5 years old ( a pilot study). - Study on the use of Leucomycin A3 (Josamycin) in severe and very severe community-acquired pneumonia of children

Teikyo University0 个研究点目标入组 100 人开始时间: 2017年3月8日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2years-old 至 5years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who fulfill any of the followings are excluded 1.Patients with severe renal dysfunction (creatinine clearance is lower than 10mL/min) 2. Patients whom the treating doctor deems, for any reason, to be ineligible. 3. Patients with underlying heart conditions i.e. congenital heart disease. 4. The patient's LAR wants to stop the study,even if after the study have started.

研究者

相似试验